Literature DB >> 30276549

Low-dose aspirin treatment enhances the adhesion of preeclamptic decidual mesenchymal stem/stromal cells and reduces their production of pro-inflammatory cytokines.

Ramin Khanabdali1,2, Aida Shakouri-Motlagh1, Sarah Wilkinson2, Padma Murthi3,4, Harry M Georgiou2, Shaun P Brennecke1,2, Bill Kalionis5,6.   

Abstract

Preeclampsia (PE) is a hypertensive disorder of human pregnancy. Low-dose aspirin (acetylsalicylic acid) (60-150 mg/day) is used to prevent PE when taken early in pregnancy. The effect of aspirin on term PE remains uncertain. Abnormal placentation is a hallmark of PE and leads to increased placental oxidative stress, which triggers the release of anti-angiogenic factors that cause local damage to the decidual vasculature. The damage subsequently spreads systemically and culminates in maternal clinical symptoms. Decidua basalis mesenchymal stem/stromal cells (DMSCs) reside in a vascular microenvironment. In PE, DMSCs are exposed to abnormally high levels of oxidative stress and circulating inflammatory factors from the maternal blood. We previously showed that colony-forming unit ability and resistance to oxidative stress in DMSCs are reduced in MSCs derived from term PE pregnancies (PE-DMSCs). The action, if any, of aspirin on term PE-DMSCs has not been reported. In this study, aspirin (5 μg/mL) was found to significantly increase PE-DMSC adhesion compared to untreated PE-DMSCs and gestation-matched control DMSCs (p value < 0.001) but had no effect on PE-DMSC proliferation. ELISA analysis showed that aspirin significantly decreased the production of inflammatory cytokines IFN-γ (p value < 0.05) and IL-8 (p value < 0.001) in PE-DMSCs. In addition, aspirin treatment increased the antioxidant capacity of PE-DMSCs compared with the untreated group (p value < 0.05). This study is the first to reveal a novel, beneficial action of aspirin on PE-DMSCs from term PE pregnancies by improving their adhesion, suppressing their production of pro-inflammatory cytokines production, and increasing their antioxidant capacity. KEY MESSAGES: Preeclampsia (PE) is a serious hypertensive disorder of pregnancy. The risk of PE is reduced by aspirin but the mechanism is poorly understood. Decidua basalis mesenchymal stem/stromal cells (DMSCs) are abnormal in PE. Aspirin treatment improves multiple functions of PE-DMSCs. Improved DMSC function may contribute to the beneficial effect of aspirin.

Entities:  

Keywords:  Aspirin; Decidua; Mesenchymal stem/stromal cells; Preeclampsia

Mesh:

Substances:

Year:  2018        PMID: 30276549     DOI: 10.1007/s00109-018-1695-9

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  35 in total

1.  Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.

Authors:  Emmanuel Bujold; Stéphanie Roberge; Yves Lacasse; Marc Bureau; François Audibert; Sylvie Marcoux; Jean-Claude Forest; Yves Giguère
Journal:  Obstet Gynecol       Date:  2010-08       Impact factor: 7.661

2.  Human mesenchymal stem cells efficiently manage oxidative stress.

Authors:  Araceli Valle-Prieto; Paulette A Conget
Journal:  Stem Cells Dev       Date:  2010-08-18       Impact factor: 3.272

3.  Aspirin and pravastatin reduce lectin-like oxidized low density lipoprotein receptor-1 expression, adhesion molecules and oxidative stress in human coronary artery endothelial cells.

Authors:  Jia-wei Chen; Shi-bei Zhou; Zhi-ming Tan
Journal:  Chin Med J (Engl)       Date:  2010-06       Impact factor: 2.628

4.  Aspirin-triggered lipoxin A₄ attenuates lipopolysaccharide-induced intracellular ROS in BV2 microglia cells by inhibiting the function of NADPH oxidase.

Authors:  Yan Wu; Heng Zhai; Yanping Wang; Longyan Li; Jing Wu; Fang Wang; Shenggang Sun; Shanglong Yao; You Shang
Journal:  Neurochem Res       Date:  2012-05-03       Impact factor: 3.996

5.  Mesenchymal stem cells reside in a vascular niche in the decidua basalis and are absent in remodelled spiral arterioles.

Authors:  G D Kusuma; U Manuelpillai; M H Abumaree; M D Pertile; S P Brennecke; B Kalionis
Journal:  Placenta       Date:  2014-12-24       Impact factor: 3.481

6.  Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis.

Authors:  S Roberge; K H Nicolaides; S Demers; P Villa; E Bujold
Journal:  Ultrasound Obstet Gynecol       Date:  2013-05       Impact factor: 7.299

7.  Aspirin treatment improved mesenchymal stem cell immunomodulatory properties via the 15d-PGJ2/PPARγ/TGF-β1 pathway.

Authors:  Jianxia Tang; Jimin Xiong; Tingting Wu; Zhangui Tang; Gang Ding; Chunmei Zhang; Songlin Wang; Yi Liu
Journal:  Stem Cells Dev       Date:  2014-07-01       Impact factor: 3.272

8.  Aspirin attenuates angiotensin II-induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF-κB activation.

Authors:  Fenxi Zhang; Ming Lu; Huaibin Wang; Tongming Ren
Journal:  Biomed Rep       Date:  2013-08-23

9.  Low-dose aspirin in pregnancy: maternal and neonatal aspirin concentrations and neonatal prostanoid formation.

Authors:  Andreas Leonhardt; Stefanie Bernert; Bernhard Watzer; Gabriele Schmitz-Ziegler; Hannsjörg W Seyberth
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

Review 10.  The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in.

Authors:  Armin Ehninger; Andreas Trumpp
Journal:  J Exp Med       Date:  2011-03-14       Impact factor: 14.307

View more
  4 in total

1.  Aspirin-Mediated Reset of Preeclamptic Placental Stem Cell Transcriptome - Implication for Stabilized Placental Function.

Authors:  Matthew P Romagano; Lauren S Sherman; Bobak Shadpoor; Markos El-Far; Sami Souayah; Sri Harika Pamarthi; Joshua Kra; Anupama Hood-Nehra; Jean-Pierre Etchegaray; Shauna F Williams; Pranela Rameshwar
Journal:  Stem Cell Rev Rep       Date:  2022-07-31       Impact factor: 6.692

2.  GNG7 silencing promotes the proliferation and differentiation of placental cytotrophoblasts in preeclampsia rats through activation of the mTOR signaling pathway.

Authors:  Wei-Si Lai; Yi-Ling Ding
Journal:  Int J Mol Med       Date:  2019-03-12       Impact factor: 4.101

Review 3.  Mesenchymal Stem/Stromal Cells and Their Role in Oxidative Stress Associated with Preeclampsia.

Authors:  Gina D Kusuma; Harry M Georgiou; Anthony V Perkins; Mohamed H Abumaree; Shaun P Brennecke; Bill Kalionis
Journal:  Yale J Biol Med       Date:  2022-03-31

Review 4.  Role of microRNAs in trophoblast invasion and spiral artery remodeling: Implications for preeclampsia.

Authors:  Heyam Hayder; Yanan Shan; Yan Chen; Jacob Anderson O'Brien; Chun Peng
Journal:  Front Cell Dev Biol       Date:  2022-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.